Transversely Polarized Drell-Yan Process and Soft Gluon Resummation in QCD

We calculate the transverse-momentum $Q_T$ spectrum of the dilepton in the transversely polarized Drell-Yan process on the basis of the factorization theorem in QCD. We take into account universal logarithmically enhanced corrections in edge region of phase space by resumming multiple soft-gluon emissions to all orders in the small $Q_T$ region.Comment: 84 pages, 5 figures, Revised version published in Prog.Theor.Phy

B meson light-cone wavefunctions in the heavy quark limit

We present a systematic study of the B meson light-cone wavefunctions in QCD in the heavy-quark limit. We construct model-independent formulae for the light-cone wavefunctions in terms of independent dynamical degrees of freedom, which exactly satisfy the QCD equations of motion and constraints from heavy-quark symmetry. The results demonstrate novel behaviors of longitudinal as well as transverse momentum distribution in the B mesons.Comment: 5 pages LaTeX, 1 style file. Talk presented at RADCOR/Loops and Legs 2002, Kloster Banz, Germany, September 8-13, 200

Q_T Resummation in Transversely Polarized Drell-Yan Process

We calculate QCD corrections to transversely polarized Drell-Yan process at a measured $Q_T$ of the produced lepton pair in the dimensional regularization scheme. The $Q_T$ distribution is discussed resumming soft gluon effects relevant for small $Q_T$.Comment: 4 pages, 1 figure, contribution to proceedings of International Conference on QCD and Hadronic Physics, Beijing, June 16-20, 200

Effective role of unpolarized nonvalence partons in Drell-Yan single spin asymmetries

We perform numerical simulations of the Sivers effect from single spin asymmetries in Drell-Yan processes on transversely polarized protons. We consider colliding antiprotons and pions at different kinematic conditions of interest for the future planned experiments. We conventionally name "framework I" the results obtained when properly accounting for the various flavor dependent polarized valence contributions in the numerator of the asymmetry, and for the unpolarized nonvalence contribution in its denominator. We name "framework II" the results obtained when taking a suitable flavor average of the valence contributions and neglecting the nonvalence ones. We compare the two methods, also with respect to the input parametrization of the Sivers function which is extracted from data with approximations sometimes intermediate between frameworks I and II. Deviations between the two approaches are found to be small except for dilepton masses below 3 GeV. The Sivers effect is used as a test case; the arguments can be generalized to other interesting azimuthal asymmetries in Drell-Yan processes, such as the Boer-Mulders effect.Comment: 13 pages, 9 figures in eps forma

Phase II trial of docetaxel, cisplatin and fluorouracil followed by carboplatin and radiotherapy in locally advanced oesophageal cancer

This study was performed to assess the efficacy and safety of docetaxel, cisplatin and fluorouracil combination in patients with unresectable locally advanced oesophageal squamous cell carcinoma. Treatment consisted of docetaxel 60 mg m−2, cisplatin 75 mg m−2 on day 1 and fluorouracil 750 mg m−2 day−1 on days 2–5, repeated every 3 weeks for three cycles, followed by carboplatin 100 mg m−2 week−1 for 5 weeks and concurrent radiotherapy (45 Gy in 25 fractions, 5 days week−1). After radiotherapy, eligible patients either underwent an oesophagectomy or received high dose rate endoluminal brachytherapy (HDR-EBT). Thirty-one out of 37 enrolled patients completed the planned chemotherapy and 30 completed chemoradiation. After completion of chemotherapy, 49% (95% CI: 32.2–66.2) had a clinical response. Twelve patients (32%) underwent a resection, which was radical in 60% (postoperative mortality: 0%). A pathological complete response was documented in four patients (11% of enrolled, 30% of resected). The median survival was 10.8 months (95% CI: 8.1–12.4), and the 1- and 2-year survival rates were 35.1 and 18.9%, respectively. Grade 3–4 toxicities were neutropoenia 32%, anaemia 11%, non-neutropoenic infections 18%, diarrhoea 6% and oesophagitis 5%. Nine patients (24%) developed a tracheo-oesophageal fistula during treatment. Even if the addition of docetaxel to cisplatin and 5-fluorouracil (5-FU) seems to be more active than the cisplatin and 5-FU combination, an incremental improvement in survival is not seen, and the toxicity observed in this study population is of concern. In order to improve the prognosis of these patients, new drugs, combinations and strategies with a better therapeutic index need to be identified

Erratum to: 36th International Symposium on Intensive Care and Emergency Medicine

[This corrects the article DOI: 10.1186/s13054-016-1208-6.]